abstract |
The present invention relates to a Factor IX variant, a molecule comprising the variant, a nucleic acid encoding the variant, a composition comprising the variant or a nucleic acid encoding the variant, and a method for regulating hemostasis, e.g., of hemophilia B and its use in prophylaxis or treatment. Factor IX variants have improved biological properties relative to other Factor IX variants and/or relative to wild-type Factor IX. |